Takayuki Shindo Selected Research

Receptor Activity-Modifying Protein 2

1/2021	Adrenomedullin-Receptor Activity-Modifying Protein 2 System Ameliorates Subretinal Fibrosis by Suppressing Epithelial-Mesenchymal Transition in Age-Related Macular Degeneration.
7/2015	Adrenomedullin-RAMP2 System in Vascular Endothelial Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takayuki Shindo Research Topics

Disease

8	Fibrosis (Cirrhosis) 01/2021 - 01/2003
6	Heart Failure 07/2022 - 01/2010
6	Neoplasms (Cancer) 05/2022 - 08/2004
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 08/2004
6	Infections 01/2016 - 04/2008
5	Hypertrophy 01/2021 - 01/2003
5	Cardiomegaly (Heart Hypertrophy) 10/2019 - 01/2003
4	Ischemia 01/2019 - 08/2004
4	Vascular System Injuries 06/2013 - 08/2002
3	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2016
3	Atrophy 05/2020 - 10/2004
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2009
3	Alcoholic Fatty Liver 01/2020 - 09/2017
3	Chronic Hepatitis (Chronic Active Hepatitis) 10/2019 - 05/2009
3	Neointima 01/2017 - 01/2003
3	Hyperplasia 06/2013 - 08/2002
3	Body Weight (Weight, Body) 05/2006 - 05/2003
2	Hypersensitivity (Allergy) 09/2022 - 10/2013
2	Obesity 11/2021 - 12/2018
2	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 06/2015
2	Choroidal Neovascularization 01/2021 - 06/2015
2	Inflammation (Inflammations) 05/2019 - 05/2017
2	Hemorrhage 01/2019 - 09/2011
2	Atherosclerosis 06/2013 - 05/2006
2	Hepatitis 05/2009 - 04/2006
2	Respiratory Hypersensitivity 06/2007 - 11/2002
1	Heart Diseases (Heart Disease) 07/2022
1	Myocardial Infarction 07/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Thoracic Aortic Aneurysm 01/2022
1	Aortic Dissection 01/2022
1	Hypertension (High Blood Pressure) 11/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021
1	Dyslipidemias (Dyslipidemia) 11/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Papilledema 05/2020
1	Nociceptive Pain 12/2019
1	Lymphedema (Milroy Disease) 12/2019
1	Cachexia 10/2019
1	Chronic Disease (Chronic Diseases) 10/2019
1	Iron Overload 05/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Edema (Dropsy) 01/2019
1	Retinal Vein Occlusion 01/2019

Drug/Important Bio-Agent (IBA)

16	AdrenomedullinIBA 11/2021 - 08/2002
10	Peptides (Polypeptides)IBA 01/2021 - 08/2004
7	Calcitonin Gene-Related PeptideIBA 01/2022 - 04/2006
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2011
5	Retinaldehyde (Retinal)IBA 05/2020 - 06/2013
4	Angiotensin IIIBA 01/2022 - 01/2003
4	Transcription Factors (Transcription Factor)IBA 01/2010 - 01/2003
3	Pharmaceutical PreparationsIBA 05/2022 - 01/2017
3	Placental ExtractsIBA 01/2020 - 09/2017
3	Choline (Choline Chloride)IBA 01/2020 - 09/2017
3	tamibaroteneIBA 05/2006 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2017
2	Receptor Activity-Modifying Protein 2IBA 01/2021 - 07/2015
2	Therapeutic UsesIBA 05/2020 - 05/2016
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2019 - 06/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 06/2011
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 01/2012
2	AcidsIBA 01/2016 - 05/2009
2	Protein Isoforms (Isoforms)IBA 01/2016 - 01/2012
2	Factor V (Coagulation Factor V)IBA 01/2010 - 01/2005
2	Concanavalin AIBA 05/2009 - 04/2006
2	RetinoidsIBA 05/2006 - 11/2005
2	ApolipoproteinsIBA 05/2006 - 08/2002
2	Histamine (Histamine Dihydrochloride)FDA Link 10/2004 - 05/2003
1	Durapatite (Hydroxylapatite)IBA 09/2022
1	titanium dioxide (Titania)FDA Link 09/2022
1	Dynamins (Dynamin)IBA 07/2022
1	Adenosine Triphosphate (ATP)IBA 07/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	IntegrinsIBA 01/2022
1	C-Reactive ProteinIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	CXC ChemokinesIBA 01/2021
1	Actins (F Actin)IBA 01/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2021
1	Adrenomedullin ReceptorsIBA 01/2021
1	Methionine (L-Methionine)FDA Link 01/2020
1	NeuropeptidesIBA 12/2019
1	IronIBA 05/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	isothiocyanic acidIBA 01/2019
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2019
1	Rose BengalIBA 01/2019

Therapy/Procedure

6	Lasers (Laser) 01/2021 - 08/2004
4	Therapeutics 01/2022 - 01/2012
2	Transplantation 05/2022 - 01/2016
1	Analgesia 01/2022
1	Ligation 01/2022
1	Intravitreal Injections 01/2021
1	Light Coagulation 01/2019